China Agrees to Halt Fentanyl Precursor Production in Deal with US
China has reached an agreement with the US to stop producing and exporting fentanyl precursors, implementing new licensing requirements to combat the deadly drug crisis and reduce US drug-related deaths.
Kash Patel says China agreed to stop production of fentanyl ingredients
Washington Examiner
Overview
- China has agreed to cease the production of fentanyl precursors, securing a significant deal with the United States government to address the ongoing drug crisis.
- The agreement involves China fully designating and listing all 13 precursor chemicals used to manufacture fentanyl, effectively shutting down the supply pipeline.
- This historic deal, attributed by Patel to President Trump's significant agreement with Chinese President Xi, aims to curb the flow of illicit fentanyl.
- The initiative comes as the U.S. recorded over 105,000 drug-related deaths in 2023, highlighting the urgent need for action against fentanyl.
- China has implemented new requirements, mandating a license to export these precursor chemicals to the United States, Canada, and Mexico.
Report issue
Read both sides in 5 minutes each day
Analysis
Analysis unavailable for this viewpoint.
Articles (4)
Center (0)
No articles found in the Center category
FAQ
China has agreed to fully designate and list all 13 precursor chemicals used to manufacture fentanyl, implement new licensing requirements mandating licenses to export these precursor chemicals to the U.S., Canada, and Mexico, effectively shutting down the supply pipeline.
The agreement aims to reduce the flow of illicit fentanyl into the US by cutting off precursor chemical supplies, thereby combating the deadly drug crisis and helping to reduce drug-related deaths in the US, which exceeded 105,000 in 2023.
The deal is attributed to a significant agreement reached between President Trump and President Xi, signaling high-level bilateral cooperation in addressing the fentanyl precursor supply chain.
US fentanyl seizures declined by 53% from January to June 2025 compared to the same period the previous year, indicating a reduction in fentanyl supply possibly linked to the agreement and related enforcement actions.
China's new licensing requirements for exporting fentanyl precursor chemicals also apply to Canada and Mexico, key countries involved in the regional drug supply chain.
History
- This story does not have any previous versions.